Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Goncalves A (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32(11):4655–4662

PubMed  Google Scholar 

Witzel I, Laakmann E, Weide R et al (2018) Treatment and outcomes of patients in the brain metastases in breast Cancer Network Registry. Eur J Cancer 102:1–9. https://doi.org/10.1016/j.ejca.2018.07.004

Article  CAS  PubMed  Google Scholar 

Gennari A, Andre F, Barrios CH et al (2021) ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol 32(12):1475–1495. https://doi.org/10.1016/j.annonc.2021.09.019

Article  CAS  PubMed  Google Scholar 

Arvold ND, Lee EQ, Mehta MP et al (2016) Updates in the management of brain metastases. Neuro Oncol 18(8):1043–1065. https://doi.org/10.1093/neuonc/now127

Article  PubMed  PubMed Central  Google Scholar 

Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15(4):387–395. https://doi.org/10.1016/S1470-2045(14)70061-0

Article  PubMed  Google Scholar 

Aversa C, Rossi V, Geuna E, Martinello R, Milani A, Redana S, Valabrega G, Aglietta M, Montemurro F (2014) Metastatic breast cancer subtypes and central nervous system metastases. Breast 23(5):623–628. https://doi.org/10.1016/j.breast.2014.06.009

Article  CAS  PubMed  Google Scholar 

Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113(10):2638–2645. https://doi.org/10.1002/cncr.23930

Article  PubMed  Google Scholar 

Koniali L, Hadjisavvas A, Constantinidou A et al (2020) Risk factors for breast cancer brain metastases: a systematic review. Oncotarget 11(6):650–669. https://doi.org/10.18632/oncotarget.27453

Article  PubMed  PubMed Central  Google Scholar 

Bailleux C, Eberst L, Bachelot T (2021) Treatment strategies for breast cancer brain metastases. Br J Cancer 124(1):142–155. https://doi.org/10.1038/s41416-020-01175-y

Article  PubMed  Google Scholar 

Chaung KV, Sloan AE, Choi S (2021) Limited brain metastases: a narrative review. Ann Palliat Med 10(5):6016–6027. https://doi.org/10.21037/apm-21-363

Article  PubMed  Google Scholar 

Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10. https://doi.org/10.1200/JCO.1995.13.1.8

Article  CAS  PubMed  Google Scholar 

Ottaiano A, Santorsola M, Caraglia M, Circelli L, Gigantino V, Botti G, Nasti G (2021) Genetic regressive trajectories in colorectal cancer: a new hallmark of oligo-metastatic disease? Transl Oncol 14(8):101131. https://doi.org/10.1016/j.tranon.2021.101131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8(6):378–382. https://doi.org/10.1038/nrclinonc.2011.44

Article  CAS  PubMed  Google Scholar 

Ottaiano A, Santorsola M, Circelli L et al (2023) Oligo-metastatic cancers: putative biomarkers, emerging challenges and New perspectives. Cancers (Basel) 15(6). https://doi.org/10.3390/cancers15061827

Iyengar P, Wardak Z, Gerber DE et al (2018) Consolidative Radiotherapy for Limited Metastatic Non-small-cell Lung Cancer: a phase 2 Randomized Clinical Trial. JAMA Oncol 4(1):e173501. https://doi.org/10.1001/jamaoncol.2017.3501

Article  PubMed  Google Scholar 

Gomez DR, Tang C, Zhang J et al (2019) Local consolidative therapy Vs. maintenance Therapy or Observation for patients with Oligometastatic Non-small-cell Lung Cancer: long-term results of a multi-institutional, phase II, Randomized Study. J Clin Oncol 37(18):1558–1565. https://doi.org/10.1200/JCO.19.00201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palma DA, Haasbeek CJ, Rodrigues GB et al (2012) Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial. BMC Cancer 12:305. https://doi.org/10.1186/1471-2407-12-305

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang WS, Kim HY, Chang JW, Park YG, Chang JH (2010) Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 113:73–78. https://doi.org/10.3171/2010.8.GKS10994

Article  PubMed  Google Scholar 

Yamamoto M, Higuchi Y, Sato Y, Aiyama H, Kasuya H, Barfod BE (2019) Stereotactic radiosurgery for patients with 10 or more brain metastases. Prog Neurol Surg 34:110–124. https://doi.org/10.1159/000493056

Article  PubMed  Google Scholar 

Hughes RT, Masters AH, McTyre ER et al (2019) Initial SRS for patients with 5 to 15 brain metastases: results of a multi-institutional experience. Int J Radiat Oncol Biol Phys 104(5):1091–1098. https://doi.org/10.1016/j.ijrobp.2019.03.052

Article  PubMed  Google Scholar 

Gondi V, Bauman G, Bradfield L et al (2022) Radiation Therapy for Brain metastases: an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12(4):265–282. https://doi.org/10.1016/j.prro.2022.02.003

Article  PubMed  Google Scholar 

Scorsetti M, Navarria P, Cozzi L et al (2023) Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform. Radiat Oncol 18(1):28. https://doi.org/10.1186/s13014-023-02216-5

Article  PubMed  PubMed Central  Google Scholar 

Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483–2491. https://doi.org/10.1001/jama.295.21.2483

Article  CAS  PubMed  Google Scholar 

Muller V, Hein A, Hartkopf AD et al (2022) Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - a retrospective analysis of a real world registry. Eur J Cancer 172:13–21. https://doi.org/10.1016/j.ejca.2022.05.015

Article  CAS  PubMed  Google Scholar 

File DM, Pascual T, Deal AM, Wheless A, Perou CM, Claire Dees E, Carey LA (2022) Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer. Breast Cancer Res Treat 196(1):153–162. https://doi.org/10.1007/s10549-022-06700-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Witzel I, Oliveira-Ferrer L, Pantel K, Muller V, Wikman H (2016) Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res 18(1):8. https://doi.org/10.1186/s13058-015-0665-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bryan S, Witzel I, Borgmann K, Oliveira-Ferrer L (2021) Molecular mechanisms Associated with Brain metastases in HER2-Positive and triple negative breast cancers. Cancers (Basel) 13(16). https://doi.org/10.3390/cancers13164137

D’Alterio C, Scala S, Sozzi G, Roz L, Bertolini G (2020) Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. Semin Cancer Biol 60:351–361. https://doi.org/10.1016/j.semcancer.2019.08.019

Article  CAS  PubMed  Google Scholar 

Aparicio S, Caldas C (2013) The implications of clonal genome evolution for cancer medicine. N Engl J Med 368(9):842–851. https://doi.org/10.1056/NEJMra1204892